hero image
hero image

Angioedema Hub will launch as an open access online independent medical education platform in collaboration with ACARE as strategic partner.


The initial focus on angioedema as a clinical manifestation of chronic urticaria will be on hereditary angioedema (HAE), due to the abundance of scientific research and interest in both HAE therapies already available and several in development.



For further information please contact Simon Walker
Brought to you by ses
In partnership with
acare focisnet
Chair head imageMarcus Maurer
Angioedema Hub Chair

There is a need for improved education across all angioedema subtypes including HA, with several interesting newly introduced and development treatment options in the pipeline.

The Angioedema Hub will launch as an open access online independent medical education platform In partnership with ACARE. The scientific & medical content strategy will be steered by a world-renowned expert steering committee and target community HCPs treating angioedema as a clinical manifestation of chronic urticaria.

We welcome support from the life sciences industry.

quote graphic
Angioedema Hub will be steered by a world renowned expert committee
The Angioedema Hub will be guided by an international steering committee of world-leading experts
Steering Committee experts will meet regularly to determine the content strategy and contribute to its development
test
Anete Grumach
São Paulo, Brazil
test
Gordon Sussman
Toronto, Canada
test
Jonathan Bernstein
Cincinnati, US
test
Marc Riedl
San Diego, US
test
Marcus Maurer
Berlin, Germany
test
Markus Magerl
Berlin, Germany
test
Michihiro Hide
Hiroshima, Japan
test
Farkas Henriette
Budapest, Hungary
test
Philip Li
Hong Kong, China
For further information please contact Simon Walker
SES Limited
112
Princes Gardens,
London,
W3 0LJ

+44 (0) 1372 472 140
SES US Inc.
300 Carnegie Center
Suite 150
Princeton,
NJ 08540

+1 (609) 786-2538
Brought to you by
SES
facebook
X
linkedin
instagram